Nano Transdermal Delivery Potential of Fucoidan from Sargassum sp. (Brown Algae) as Chemoprevention Agent for Breast Cancer Treatment
Pharmacognosy Journal · 09.01.2023 · 14 (6) · 789-795
DOI: 10.5530/pj.2022.14.169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacognosy Journal, online erschienen am 09.01.2023. Verfasst von Syeftyan Muhammad Ali Hamami und 20 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Conventional chemotherapy substances are associated with mild to severe side effects that affect both healthy and cancer cells. It is presumed to improve therapeutic efficacy in coexistence reducing chemotherapy’s side effects. Fucoidan is an anticancer bioactive compound derived from Sargassum sp. that has low cytotoxic activity. The purpose of this study was to explore the effectiveness of anticancer activities of fucoidan from Sargassum sp. against breast cancer then analyze the suitability of nano transdermal patch of fucoidan and blueprint the long-term research design of nano transdermal patch as a chemoprevention agent in the chemotherapeutic management of breast cancer. This research was performed through a literature study and in silico study by imposing carbonic anhydrase IX (CA IX) as a marker of hypoxia and metastatic state of cancer cells. The results showed that the fucoidan from Sargassum sp. effectively induced apoptosis and prevented metastasis of breast cancer cells through the Bcl-2, Bcl-w, and bad pathways. Fucoidan, in addition, was predicted to inhibit CA IX by Glu4 Glu5, Leu7, Pro8, and Asp6 residues. Therefore, the delivery of fucoidan is favored to have a local effect on the site of breast cancer cells by nano transdermal patch preparations using fucoidan nanoparticle polymer. Further nano transdermal patch development as a treatment for breast cancer is suggested through the stages of formulation optimization, optimum formula activity testing, patent filing, and distribution in health services.
Zitieren
APA
Hamami, S. M. A., Fai, M., Aththar, A. F., Zakaria, M. N. Z., Kharisma, V. D., Murtadlo, A. A. A., Tamam, M. B., Jakhmola, V., Widyananda, M. H., Turista, D. D. R., Rebezov, M., Maksimiuk, N., Kulmakova, N., Latynina, E., Ansori, A., Zainul, R., Mandeli, R. S., Purnamasari, D., Illiandri, O., …, & Fitri, E. (2023). Nano Transdermal Delivery Potential of Fucoidan from Sargassum sp. (Brown Algae) as Chemoprevention Agent for Breast Cancer Treatment. Pharmacognosy Journal, 14(6), 789-795. https://doi.org/10.5530/pj.2022.14.169
Vancouver
Hamami SMA, Fai M, Aththar AF, Zakaria MNZ, Kharisma VD, Murtadlo AAA, et al. Nano Transdermal Delivery Potential of Fucoidan from Sargassum sp. (Brown Algae) as Chemoprevention Agent for Breast Cancer Treatment. Pharmacognosy Journal. 2023;14(6):789-795. doi:10.5530/pj.2022.14.169
BibTeX
@article{Hamami2023,
author = {Hamami, Syeftyan Muhammad Ali and Fai, Michelle and Aththar, Ahmad Fariduddin and Zakaria, M Nizam Zulfi and Kharisma, Viol Dhea and Murtadlo, Ahmad Affan Ali and Tamam, Muhammad Badrut and Jakhmola, Vikash and Widyananda, Muhammad Hermawan and Turista, Dora Dayu Rahma and Rebezov, Maksim and Maksimiuk, Nikolai and Kulmakova, Nataliya and Latynina, Evgeniya and Ansori, ANM and Zainul, Rahadian and Mandeli, Riso Sari and Purnamasari, Devi and Illiandri, Oski and Nisyak, Khoirun and Fitri, Ernarisa},
title = {Nano Transdermal Delivery Potential of Fucoidan from Sargassum sp. (Brown Algae) as Chemoprevention Agent for Breast Cancer Treatment},
journal = {Pharmacognosy Journal},
year = {2023},
volume = {14},
number = {6},
pages = {789--795},
doi = {10.5530/pj.2022.14.169}
}
EUVIMED